Who owns FREELINE THERAPEUTICS HOLDINGS?
- CUSIP Number: 35655l206
Tip: Access positions for across all investors
Analyze quarterly positions in Freeline Therapeutics Holdings with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Freeline Therapeutics Holdings stock
Who bought or sold FREELINE THERAPEUTICS HOLDINGS this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| UBS Group | 99k | $633k | 190% | Dec 2023 |
|
| Blue Owl Capital Holdings | 87k | $552k | 100% | Dec 2023 |
|
| Jpmorgan Chase & Co | 67k | $427k | 100% | Dec 2023 |
|
| PenderFund Capital Management | 60k | $509k | 100% | Dec 2023 |
|
| Harbor Capital Advisors | 20k | $129k | 63% | Dec 2023 |
|
| Sphera Funds Management | 16k | $105k | 100% | Dec 2023 |
|
| Rhumbline Advisers | 155.00 | $984.994000 | 35% | Dec 2023 |
|
| Gradient Investments | 100.00 | $637.000000 | 100% | Dec 2023 |
|
Who sold out of Freeline Therapeutics Holdings?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Millennium Management | Sep 2023 | 371k | $1.6M |
| Polygon Management | Sep 2023 | 267k | $1.1M |